Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Am J Kidney Dis. 2018 Apr 23;72(2):168–177. doi: 10.1053/j.ajkd.2018.01.058

Figure 4. Adjusted odds and 95% confidence intervals of ACEi/ARB prescription and albuminuria quantification among patients randomized to the CKD registry vs. usual care registry.

Figure 4

(A) ACEi/ARB prescription; (B) albuminuria quantification. Results are displayed for three patient groups: all patients with CKD (n=575), patients with CKD stage 3 & 4 (n=403), and patients with uncontrolled BP at baseline (n=207). Models are adjusted for age, gender, race/ethnicity, clinic, participation in a health coaching study, as well as primary care team, primary care provider and patient clustering. *denominator is 715